Inventor
XING XUECHAO
US53 patents
⚠️ This page may combine multiple inventors who share the name “XING XUECHAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ENANTA PHARM INC
48 patentsUS10683279B2Jun 16, 2020
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC13 citations94
US11560368B2Jan 24, 2023
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC6 citations86
US11420976B2Aug 23, 2022
Heterocyclic compounds as anti-viral agents
ENANTA PHARM INC7 citations86
US11384090B2Jul 12, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC14 citations86
US11352363B1Jun 7, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC13 citations86
US11325916B1May 10, 2022
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC16 citations85
US10988458B2Apr 27, 2021
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC7 citations84
US10676500B2Jun 9, 2020
Process for preparation of sulfonyl carbamate bile acid derivatives
ENANTA PHARM INC7 citations84
US10457703B2Oct 29, 2019
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC8 citations84
US10450306B2Oct 22, 2019
Isoxazole analogs as FXR agonists and methods of use thereof
ENANTA PHARM INC7 citations84
US10450301B2Oct 22, 2019
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC11 citations84
US10253018B2Apr 9, 2019
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC10 citations84
US10246439B2Apr 2, 2019
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC12 citations84
US10208081B2Feb 19, 2019
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC9 citations84
US11919910B2Mar 5, 2024
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC5 citations74
US12018017B2Jun 25, 2024
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC1 citations73
US11958879B2Apr 16, 2024
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC1 citations73
US11834436B2Dec 5, 2023
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC2 citations73
US11718641B2Aug 8, 2023
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC1 citations73
US11040998B2Jun 22, 2021
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC2 citations73
US10968249B2Apr 6, 2021
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US10696713B2Jun 30, 2020
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US10472386B2Nov 12, 2019
Bile acid derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC6 citations73
US10149835B2Dec 11, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC2 citations73
US10080743B2Sep 25, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC4 citations73
US10080741B2Sep 25, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US10080742B2Sep 25, 2018
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC3 citations73
US12552777B2Feb 17, 2026
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations63
US12459923B2Nov 4, 2025
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations63
US11034684B2Jun 15, 2021
Isoxazole analogs as FXR agonists and methods of use thereof
ENANTA PHARM INC1 citations63
US11008304B2May 18, 2021
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC1 citations63
US10829486B2Nov 10, 2020
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC1 citations63
US10689391B2Jun 23, 2020
Isoxazole analogs as FXR agonists and methods of use thereof
ENANTA PHARM INC2 citations63
US10597391B2Mar 24, 2020
Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC1 citations63
US10266560B2Apr 23, 2019
Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC1 citations63
US10144729B2Dec 4, 2018
Isoxazole analogs as FXR agonists and methods of use thereof
ENANTA PHARM INC2 citations63
US12281140B2Apr 22, 2025
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC0 citations62
US10961272B2Mar 30, 2021
Process for preparation of sulfonyl carbamate bile acid derivatives
ENANTA PHARM INC0 citations62
US11976084B2May 7, 2024
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations52
US11945824B2Apr 2, 2024
Heterocyclic compounds as anti-viral agents
ENANTA PHARM INC0 citations52
US11555032B2Jan 17, 2023
Isoxazole derivatives as FXR agonists and methods of use thereof
ENANTA PHARM INC0 citations52
US11345699B2May 31, 2022
Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations52
US10138228B2Nov 27, 2018
Isoxazole derivatives as FXR agonists and methods of use therof
ENANTA PHARM INC1 citations52
US12540141B2Feb 3, 2026
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US12479854B2Nov 25, 2025
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US12145942B2Nov 19, 2024
Spiropyrrolidine derived antiviral agents
ENANTA PHARM INC0 citations51
US12384753B2Aug 12, 2025
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
ENANTA PHARM INC0 citations50
US10519191B2Dec 31, 2019
Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
ENANTA PHARM INC0 citations42
TUFTS COLLEGE
2 patentsShowing the top 50 of 53 patents by PatentIndex Score.